Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder".
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 11, 2022
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality.
Journal: BMC psychiatry
Published: June 22, 2022
Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression.
Journal: Neuropsychiatric disease and treatment
Published: January 22, 2022
Patient profiles, initial hospital encounter characteristics, and hospital re-encounters of patients with a hospital emergency department visit or inpatient admission for major depressive disorder.
Journal: Journal of medical economics
Published: January 20, 2022
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials.
Journal: Neuropsychiatric disease and treatment
Published: September 14, 2021
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.
Journal: Patient preference and adherence
Published: June 01, 2021
Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials.
Journal: Neuropsychiatric disease and treatment
Published: April 15, 2021
Comments to Drs. Bahji, Vazquez, and Zarate.
Journal: Journal of affective disorders
Published: November 16, 2020
Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks' Treatment in Patients with Clinically Stable Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: October 15, 2020
Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate.
Journal: Comprehensive psychiatry
Published: October 09, 2020
Last Updated: 09/26/2026